Table 3.
OTC DIPH/DOX use by gender and age group
| Overall (n = 169) | OTC DIPH/DOX use 99 (58.6) | OTC DIPH/DOX use for more than 10 days per month 35 (20.7) | ||
|---|---|---|---|---|
| Female (n = 110) | Male (n = 59) | Female (n = 110) | Male (n = 59) | |
| Gender | 65 (59.1) | 34 (57.6) | 21 (19.1) | 14 (23.7) |
| Age group | Female | Male | Female | Male |
| 65–69 (n = 24) | 13 (65.0) | 2 (50.0) | 7 (35.0) | 0 (0.0) |
| 70–74 (n = 40) | 17 (58.6) | 7 (63.6) | 3 (10.3) | 3 (27.3) |
| 75–79 (n = 39) | 16 (59.3) | 7 (58.3) | 6 (22.2) | 3 (25.0) |
| 80–84 (n = 24) | 6 (50.0) | 9 (75.0) | 2 (16.7) | 2 (16.7) |
| 85–89 (n = 25) | 8 (57.1) | 7 (63.6) | 1 (7.1) | 4 (36.4) |
| 90 + (n = 17) | 5 (62.5) | 2 (22.2) | 2 (25.0) | 2 (22.2) |